Chairman
David has over 15 years of experience working with pharmaceutical organisations in various management positions. He was first introduced to pulmonary hypertension (PH) in 2008 through his work with Amin and the PH Patient Support Group. He has an interest in helping to raise awareness of PH and the daily difficulties faced by patients. David also hopes to address the gap in funding for life-saving treatments currently available for PH.